Dec. 21, 2024 – Dec. 31, 2024 • New York, NY, USA, New York ...
The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest ...
Novo shares lost nearly a fifth of their value after an experimental combination treatment called cagrisema fell short of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback